Report Detail
Global Gastroparesis Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4529159 |
- 13 April, 2023 |
- Global |
- 90 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
According to our (Global Info Research) latest study, the global Gastroparesis Drugs market size was valued at USD 5822.8 million in 2022 and is forecast to a readjusted size of USD 7722 million by 2029 with a CAGR of 4.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest consumer of Gastroparesis Drugs in global market.The second place is Europe, following North America.
Market is not concentrated. Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva and Johnson & Johnsonare the leaders of the industry, and hold the key technologies and patent, with high-end customers.
This report is a detailed and comprehensive analysis for global Gastroparesis Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Gastroparesis Drugs market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/mg), 2018-2029
Global Gastroparesis Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/mg), 2018-2029
Global Gastroparesis Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/mg), 2018-2029
Global Gastroparesis Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/mg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gastroparesis Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gastroparesis Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva and Johnson & Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Gastroparesis Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Prokinetic Agents
Antiemetic Agents
Others
Market segment by Application
Diabetic Gastroparesis
Idiopathic Gastroparesis
Major players covered
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastroparesis Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Gastroparesis Drugs, with price, sales, revenue and global market share of Gastroparesis Drugs from 2018 to 2023.
Chapter 3, the Gastroparesis Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastroparesis Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Gastroparesis Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Gastroparesis Drugs.
Chapter 14 and 15, to describe Gastroparesis Drugs sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Gastroparesis Drugs
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Gastroparesis Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Prokinetic Agents
- 1.3.3 Antiemetic Agents
- 1.3.4 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Gastroparesis Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Diabetic Gastroparesis
- 1.4.3 Idiopathic Gastroparesis
- 1.5 Global Gastroparesis Drugs Market Size & Forecast
- 1.5.1 Global Gastroparesis Drugs Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Gastroparesis Drugs Sales Quantity (2018-2029)
- 1.5.3 Global Gastroparesis Drugs Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Sumitomo
- 2.1.1 Sumitomo Details
- 2.1.2 Sumitomo Major Business
- 2.1.3 Sumitomo Gastroparesis Drugs Product and Services
- 2.1.4 Sumitomo Gastroparesis Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Sumitomo Recent Developments/Updates
- 2.2 Cadila Pharmaceuticals
- 2.2.1 Cadila Pharmaceuticals Details
- 2.2.2 Cadila Pharmaceuticals Major Business
- 2.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Product and Services
- 2.2.4 Cadila Pharmaceuticals Gastroparesis Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Cadila Pharmaceuticals Recent Developments/Updates
- 2.3 Sanofi
- 2.3.1 Sanofi Details
- 2.3.2 Sanofi Major Business
- 2.3.3 Sanofi Gastroparesis Drugs Product and Services
- 2.3.4 Sanofi Gastroparesis Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Sanofi Recent Developments/Updates
- 2.4 Teva
- 2.4.1 Teva Details
- 2.4.2 Teva Major Business
- 2.4.3 Teva Gastroparesis Drugs Product and Services
- 2.4.4 Teva Gastroparesis Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Teva Recent Developments/Updates
- 2.5 Johnson & Johnson
- 2.5.1 Johnson & Johnson Details
- 2.5.2 Johnson & Johnson Major Business
- 2.5.3 Johnson & Johnson Gastroparesis Drugs Product and Services
- 2.5.4 Johnson & Johnson Gastroparesis Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Johnson & Johnson Recent Developments/Updates
- 2.6 Pfizer
- 2.6.1 Pfizer Details
- 2.6.2 Pfizer Major Business
- 2.6.3 Pfizer Gastroparesis Drugs Product and Services
- 2.6.4 Pfizer Gastroparesis Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Pfizer Recent Developments/Updates
- 2.7 Kyowa Kirin Pharmaceuticals
- 2.7.1 Kyowa Kirin Pharmaceuticals Details
- 2.7.2 Kyowa Kirin Pharmaceuticals Major Business
- 2.7.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product and Services
- 2.7.4 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Kyowa Kirin Pharmaceuticals Recent Developments/Updates
- 2.8 Hanmi Pharm
- 2.8.1 Hanmi Pharm Details
- 2.8.2 Hanmi Pharm Major Business
- 2.8.3 Hanmi Pharm Gastroparesis Drugs Product and Services
- 2.8.4 Hanmi Pharm Gastroparesis Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Hanmi Pharm Recent Developments/Updates
- 2.9 Ani Pharmaceuticals
- 2.9.1 Ani Pharmaceuticals Details
- 2.9.2 Ani Pharmaceuticals Major Business
- 2.9.3 Ani Pharmaceuticals Gastroparesis Drugs Product and Services
- 2.9.4 Ani Pharmaceuticals Gastroparesis Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Ani Pharmaceuticals Recent Developments/Updates
3 Competitive Environment: Gastroparesis Drugs by Manufacturer
- 3.1 Global Gastroparesis Drugs Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Gastroparesis Drugs Revenue by Manufacturer (2018-2023)
- 3.3 Global Gastroparesis Drugs Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Gastroparesis Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Gastroparesis Drugs Manufacturer Market Share in 2022
- 3.4.2 Top 6 Gastroparesis Drugs Manufacturer Market Share in 2022
- 3.5 Gastroparesis Drugs Market: Overall Company Footprint Analysis
- 3.5.1 Gastroparesis Drugs Market: Region Footprint
- 3.5.2 Gastroparesis Drugs Market: Company Product Type Footprint
- 3.5.3 Gastroparesis Drugs Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Gastroparesis Drugs Market Size by Region
- 4.1.1 Global Gastroparesis Drugs Sales Quantity by Region (2018-2029)
- 4.1.2 Global Gastroparesis Drugs Consumption Value by Region (2018-2029)
- 4.1.3 Global Gastroparesis Drugs Average Price by Region (2018-2029)
- 4.2 North America Gastroparesis Drugs Consumption Value (2018-2029)
- 4.3 Europe Gastroparesis Drugs Consumption Value (2018-2029)
- 4.4 Asia-Pacific Gastroparesis Drugs Consumption Value (2018-2029)
- 4.5 South America Gastroparesis Drugs Consumption Value (2018-2029)
- 4.6 Middle East and Africa Gastroparesis Drugs Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Gastroparesis Drugs Sales Quantity by Type (2018-2029)
- 5.2 Global Gastroparesis Drugs Consumption Value by Type (2018-2029)
- 5.3 Global Gastroparesis Drugs Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Gastroparesis Drugs Sales Quantity by Application (2018-2029)
- 6.2 Global Gastroparesis Drugs Consumption Value by Application (2018-2029)
- 6.3 Global Gastroparesis Drugs Average Price by Application (2018-2029)
7 North America
- 7.1 North America Gastroparesis Drugs Sales Quantity by Type (2018-2029)
- 7.2 North America Gastroparesis Drugs Sales Quantity by Application (2018-2029)
- 7.3 North America Gastroparesis Drugs Market Size by Country
- 7.3.1 North America Gastroparesis Drugs Sales Quantity by Country (2018-2029)
- 7.3.2 North America Gastroparesis Drugs Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Gastroparesis Drugs Sales Quantity by Type (2018-2029)
- 8.2 Europe Gastroparesis Drugs Sales Quantity by Application (2018-2029)
- 8.3 Europe Gastroparesis Drugs Market Size by Country
- 8.3.1 Europe Gastroparesis Drugs Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Gastroparesis Drugs Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Gastroparesis Drugs Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Gastroparesis Drugs Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Gastroparesis Drugs Market Size by Region
- 9.3.1 Asia-Pacific Gastroparesis Drugs Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Gastroparesis Drugs Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Gastroparesis Drugs Sales Quantity by Type (2018-2029)
- 10.2 South America Gastroparesis Drugs Sales Quantity by Application (2018-2029)
- 10.3 South America Gastroparesis Drugs Market Size by Country
- 10.3.1 South America Gastroparesis Drugs Sales Quantity by Country (2018-2029)
- 10.3.2 South America Gastroparesis Drugs Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Gastroparesis Drugs Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Gastroparesis Drugs Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Gastroparesis Drugs Market Size by Country
- 11.3.1 Middle East & Africa Gastroparesis Drugs Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Gastroparesis Drugs Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Gastroparesis Drugs Market Drivers
- 12.2 Gastroparesis Drugs Market Restraints
- 12.3 Gastroparesis Drugs Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Gastroparesis Drugs and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Gastroparesis Drugs
- 13.3 Gastroparesis Drugs Production Process
- 13.4 Gastroparesis Drugs Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Gastroparesis Drugs Typical Distributors
- 14.3 Gastroparesis Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Gastroparesis Drugs. Industry analysis & Market Report on Gastroparesis Drugs is a syndicated market report, published as Global Gastroparesis Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Gastroparesis Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
